Small bowel capsule endoscopy and treat-to-target in Crohn's disease: A systematic review.
Inflammatory bowel disease
Monitoring
Mucosal healing
Post-operative recurrence
Prognosis
Treat-to-target
Wireless capsule endoscopy
Journal
World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448
Informations de publication
Date de publication:
21 Aug 2019
21 Aug 2019
Historique:
received:
26
03
2019
revised:
28
05
2019
accepted:
19
07
2019
entrez:
10
9
2019
pubmed:
10
9
2019
medline:
15
2
2020
Statut:
ppublish
Résumé
Crohn's disease (CD) can affect the entire gastrointestinal tract. Proximal small bowel (SB) lesions are associated with a significant risk of stricturing disease and multiple abdominal surgeries. The assessment of SB in patients with CD is therefore necessary because it may have a significant impact on prognosis with potential therapeutic implications. Because of the weak correlation that exists between symptoms and endoscopic disease activity, the "treat-to-target" paradigm has been developed, and the associated treatment goal is to achieve and maintain deep remission, encompassing both clinical and endoscopic remission. Small bowel capsule endoscopy (SBCE) allows to visualize the mucosal surface of the entire SB. At that time, there is no recommendation regarding the use of SBCE during follow-up. To investigate the impact of SBCE in a treat-to-target strategy in patients with CD. An electronic literature search was conducted in PubMed and Cochrane library using the following search terms: "capsule endoscopy", in combination with "Crohn's disease" and "treat-to-target" or synonyms. Two authors independently reviewed titles and abstracts identified by the search strategy after duplicates were removed. Following the initial screening of abstracts, all articles containing information about SBCE in the context of treat-to-target strategy in patients with CD were included. Full-text articles were retrieved, reference lists were screened manually to identify additional studies. Forty-seven articles were included in this review. Two indexes are currently used to quantify disease activity using SBCE, and there is good correlation between them. SBCE was shown to be useful for disease reclassification in patients who are suspected of having or who are diagnosed with CD, with a significant incremental diagnostic yield compared to other diagnostic modalities. Nine studies also demonstrated that the mucosal healing can be evaluated by SBCE to monitor the effect of medical treatment in patients with CD. This review also demonstrated that SBCE can detect post-operative recurrence to a similar extent as ileocolonoscopy, and proximal SB lesions that are beyond the reach of the colonoscope in over half of the patients. SBCE could be incorporated in the treat-to-target algorithm for patients with CD. Randomized controlled trials are required to confirm its usefulness and reliability in this indication.
Sections du résumé
BACKGROUND
BACKGROUND
Crohn's disease (CD) can affect the entire gastrointestinal tract. Proximal small bowel (SB) lesions are associated with a significant risk of stricturing disease and multiple abdominal surgeries. The assessment of SB in patients with CD is therefore necessary because it may have a significant impact on prognosis with potential therapeutic implications. Because of the weak correlation that exists between symptoms and endoscopic disease activity, the "treat-to-target" paradigm has been developed, and the associated treatment goal is to achieve and maintain deep remission, encompassing both clinical and endoscopic remission. Small bowel capsule endoscopy (SBCE) allows to visualize the mucosal surface of the entire SB. At that time, there is no recommendation regarding the use of SBCE during follow-up.
AIM
OBJECTIVE
To investigate the impact of SBCE in a treat-to-target strategy in patients with CD.
METHODS
METHODS
An electronic literature search was conducted in PubMed and Cochrane library using the following search terms: "capsule endoscopy", in combination with "Crohn's disease" and "treat-to-target" or synonyms. Two authors independently reviewed titles and abstracts identified by the search strategy after duplicates were removed. Following the initial screening of abstracts, all articles containing information about SBCE in the context of treat-to-target strategy in patients with CD were included. Full-text articles were retrieved, reference lists were screened manually to identify additional studies.
RESULTS
RESULTS
Forty-seven articles were included in this review. Two indexes are currently used to quantify disease activity using SBCE, and there is good correlation between them. SBCE was shown to be useful for disease reclassification in patients who are suspected of having or who are diagnosed with CD, with a significant incremental diagnostic yield compared to other diagnostic modalities. Nine studies also demonstrated that the mucosal healing can be evaluated by SBCE to monitor the effect of medical treatment in patients with CD. This review also demonstrated that SBCE can detect post-operative recurrence to a similar extent as ileocolonoscopy, and proximal SB lesions that are beyond the reach of the colonoscope in over half of the patients.
CONCLUSION
CONCLUSIONS
SBCE could be incorporated in the treat-to-target algorithm for patients with CD. Randomized controlled trials are required to confirm its usefulness and reliability in this indication.
Identifiants
pubmed: 31496630
doi: 10.3748/wjg.v25.i31.4534
pmc: PMC6710184
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4534-4554Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Références
Inflamm Bowel Dis. 2000 Feb;6(1):8-15
pubmed: 10701144
Dis Manag. 2004 Winter;7(4):292-304
pubmed: 15671786
Gastrointest Endosc. 2005 Feb;61(2):255-61
pubmed: 15729235
Can J Gastroenterol. 2005 Sep;19 Suppl A:5A-36A
pubmed: 16151544
Gut. 2006 Aug;55(8):1124-30
pubmed: 16361306
Gut. 2006 Jul;55(7):978-83
pubmed: 16401689
Dig Liver Dis. 2006 May;38(5):331-5
pubmed: 16569524
Inflamm Bowel Dis. 2007 Feb;13(2):152-5
pubmed: 17206697
Inflamm Bowel Dis. 2007 Oct;13(10):1256-65
pubmed: 17577246
Gastrointest Endosc. 2007 Sep;66(3):533-40
pubmed: 17725942
Aliment Pharmacol Ther. 2008 Jan 15;27(2):146-54
pubmed: 17956598
Dig Dis Sci. 2008 Jul;53(7):1933-7
pubmed: 18034304
Gastrointest Endosc. 2008 May;67(6):902-9
pubmed: 18355824
Inflamm Bowel Dis. 2008 Nov;14(11):1542-7
pubmed: 18521929
Inflamm Bowel Dis. 2009 Apr;15(4):551-7
pubmed: 19067420
Am J Gastroenterol. 2009 Jan;104(1):219-27
pubmed: 19098872
Dig Dis Sci. 2010 Feb;55(2):411-4
pubmed: 19255845
Eur J Gastroenterol Hepatol. 2009 Aug;21(8):866-71
pubmed: 19417679
Am J Gastroenterol. 2009 Nov;104(11):2734-9
pubmed: 19584828
Endoscopy. 2009 Jul;41(7):618-37
pubmed: 19588292
Ann Intern Med. 2009 Aug 18;151(4):W65-94
pubmed: 19622512
Gastrointest Endosc. 2010 Jan;71(1):121-7
pubmed: 19863957
World J Gastroenterol. 2009 Dec 7;15(45):5685-92
pubmed: 19960565
World J Gastroenterol. 2010 Jul 14;16(26):3299-304
pubmed: 20614486
Inflamm Bowel Dis. 2010 Oct;16(10):1663-8
pubmed: 20848457
Scand J Gastroenterol. 2011 Feb;46(2):227-35
pubmed: 20977386
Gastroenterology. 2011 May;140(6):1785-94
pubmed: 21530745
Inflamm Bowel Dis. 2011 Jun;17(6):1314-21
pubmed: 21560194
Gastroenterology. 1990 Apr;98(4):811-8
pubmed: 2179031
Inflamm Bowel Dis. 2011 Sep;17(9):1855-62
pubmed: 21830264
Dig Dis Sci. 2012 Apr;57(4):987-93
pubmed: 22057284
Int J Colorectal Dis. 2012 Apr;27(4):521-5
pubmed: 22065113
Endoscopy. 2012 Jan;44(1):21-6
pubmed: 22125196
J Crohns Colitis. 2012 Jul;6(6):692-7
pubmed: 22398099
J Clin Gastroenterol. 2012 Nov-Dec;46(10):e92-5
pubmed: 22495816
Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1099-104
pubmed: 22668872
Am J Gastroenterol. 2013 Jan;108(1):106-12
pubmed: 23229423
Dig Liver Dis. 2013 Jul;45(7):558-61
pubmed: 23238033
Eur J Gastroenterol Hepatol. 2013 Jun;25(6):706-13
pubmed: 23325280
Saudi J Gastroenterol. 2013 Mar-Apr;19(2):63-8
pubmed: 23481131
Inflamm Bowel Dis. 2013 Jun;19(7):1390-6
pubmed: 23552764
Curr Med Res Opin. 2013 Sep;29(9):1171-85
pubmed: 23790243
Gastroenterology. 1990 Oct;99(4):956-63
pubmed: 2394349
Gut. 2014 Jan;63(1):88-95
pubmed: 23974954
Clin Gastroenterol Hepatol. 2015 Jun;13(6):1042-50.e2
pubmed: 24036054
Eur J Gastroenterol Hepatol. 2014 Feb;26(2):137-45
pubmed: 24220156
J Gastroenterol Hepatol. 2014 May;29(5):992-6
pubmed: 24325204
J Crohns Colitis. 2014 Dec;8(12):1610-5
pubmed: 24631311
World J Gastrointest Endosc. 2014 Mar 16;6(3):88-98
pubmed: 24634713
J Crohns Colitis. 2014 Dec;8(12):1616-23
pubmed: 24666976
J Crohns Colitis. 2014 Dec;8(12):1601-9
pubmed: 25257546
Endoscopy. 2015 Apr;47(4):330-5
pubmed: 25412092
Dig Dis Sci. 2015 Jun;60(6):1743-7
pubmed: 25559755
Endoscopy. 2015 Apr;47(4):352-76
pubmed: 25826168
Inflamm Bowel Dis. 2015 Nov;21(11):2726-35
pubmed: 26193349
Am J Gastroenterol. 2015 Sep;110(9):1316-23
pubmed: 26215531
Am J Gastroenterol. 2015 Sep;110(9):1324-38
pubmed: 26303131
Eur Rev Med Pharmacol Sci. 2015 Dec;19(23):4553-7
pubmed: 26698252
J Crohns Colitis. 2016 May;10(5):525-31
pubmed: 26748404
Ann Gastroenterol. 2016 Apr-Jun;29(2):196-200
pubmed: 27064840
Therap Adv Gastroenterol. 2016 Sep;9(5):655-63
pubmed: 27582877
Endosc Int Open. 2016 Sep;4(9):E964-9
pubmed: 27652302
Gastrointest Endosc. 2017 Jan;85(1):196-205.e1
pubmed: 27658907
J Crohns Colitis. 2017 Jan;11(1):3-25
pubmed: 27660341
J Crohns Colitis. 2017 Feb;11(2):135-149
pubmed: 27660342
Ann Gastroenterol. 2017;30(2):168-178
pubmed: 28243037
Scand J Gastroenterol. 2017 Aug;52(8):840-845
pubmed: 28431493
Expert Rev Gastroenterol Hepatol. 2017 Oct;11(10):979-993
pubmed: 28737439
Medicine (Baltimore). 2017 Aug;96(33):e7780
pubmed: 28816962
Gastrointest Endosc. 2017 Dec;86(6):1070-1078
pubmed: 28947363
Gastrointest Endosc. 2018 Jun;87(6):1489-1498
pubmed: 29355520
Dig Dis Sci. 2018 Mar;63(3):768-774
pubmed: 29380174
Therap Adv Gastroenterol. 2018 Jan 14;11:1756283X17747780
pubmed: 29399042
Scand J Gastroenterol. 2018 Apr;53(4):426-429
pubmed: 29447487
Inflamm Bowel Dis. 2018 Mar 19;24(4):775-780
pubmed: 29506048
Am J Gastroenterol. 2018 Apr;113(4):481-517
pubmed: 29610508
Diagn Ther Endosc. 2018 Jan 29;2018:9416483
pubmed: 29622900
Therap Adv Gastroenterol. 2018 Apr 09;11:1756284818765908
pubmed: 29662538
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):861-867
pubmed: 29697457
Inflamm Bowel Dis. 2018 Jun 8;24(7):1582-1588
pubmed: 29788055
Inflamm Bowel Dis. 2018 Jun 8;24(7):1566-1574
pubmed: 29893950
Therap Adv Gastroenterol. 2018 Jun 05;11:1756284818777938
pubmed: 29899757
J Clin Med. 2018 Sep 29;7(10):null
pubmed: 30274238
Endoscopy. 1980 Nov;12(6):288-94
pubmed: 7428736
Gut. 1994 Feb;35(2):231-5
pubmed: 7508411